RT Journal Article
SR Electronic
A1 Coltrera, Francesca
T1 Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 8
SP 11
OP 11
DO 10.1177/1559897715588285
UL http://mdc.sagepub.com/content/15/8/11.1.abstract
AB A trend toward the modest extension of progression-free survival and overall survival was seen in a subgroup of non–small cell lung cancer patients in this phase 2 randomized double-blind trial of veliparib combined with carboplatin and paclitaxel compared with carboplatin and paclitaxel alone.